Nanjing Vazyme Biotech. (688105.SHG) Q2 2023 Earnings

29AugExpected
Q2 2022
Q3 2022
Q1 2023
Q2 2023
-0.38
-0.1
0.18
0.46

Details

Expected EPS
0.17
Actual EPS
-0.07
Surprise EPS
-0.24
Surprise Percent
+141.18%

Description

Nanjing Vazyme Biotech. (688105.SHG) has reported earnings of -0.07 per share for Q2 2023.

0 Comments

Share your thoughts